Lazid-TP 250mg/31.25mg Injection
Marketer
Allenge India
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Lazid-TP 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance. Consistent adherence to the prescribed schedule is crucial; prematurely halting treatment compromises efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician about all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are vital for optimal recovery. Your doctor may order tests to monitor treatment response.
Uses of Lazid-TP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Lazid-TP 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Lazid-TP 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Lazid-TP 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-administration is strictly prohibited.
How Lazid-TP 250mg/31.25mg Injection works:
Ceftazidime/Tazobactam injection (Lazid-TP 250mg/31.25mg) combines the antibiotic ceftazidime with the beta-lactamase inhibitor tazobactam. Ceftazidime's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Tazobactam counters bacterial resistance mechanisms, thereby boosting ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Lazid-TP 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Lazid-TP 250mg/31.25mg is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Lazid-TP, 250mg/31.25mg, is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
The injection Lazid-TP 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Lazid-TP 250mg/31.25mg Injection to individuals with impaired renal function. Dosage modification of Lazid-TP 250mg/31.25mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Lazid-TP 250mg/31.25mg, requires careful administration to individuals with significant hepatic impairment. Dosage modification for Lazid-TP 250mg/31.25mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Lazid-TP 250mg/31.25mg Injection :
Omit a Lazid-TP 250mg/31.25mg Injection dose? Seek medical advice.
Facts to Know About Lazid-TP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Drugs combating infection |
3,018 People bought this recently